Synapse

← Journal of Liver Cancer

Papers in Journal of Liver Cancer

Page 1 · newest first

  1. Lower recurrence after ablation for MASLD-related versus alcohol-related hepatocellular carcinomaJournal of Liver Cancer · 2026
  2. Impact of albumin-bilirubin score change on prognosis in hepatocellular carcinomia treated with tyrosine kinase inhibitors: a single-center real-world studyJournal of Liver Cancer · 2026
  3. Strategic driving of the cancer-immunity cycle in HCC: roles of immune, molecular-targeted, and locoregional therapiesJournal of Liver Cancer · 2026
  4. Toward a future role for liver biopsy in HCC: literature evidence and survey-based perspectives from Korean expertsJournal of Liver Cancer · 2026
  5. Clinical features, treatment patterns, and outcomes of young-onset hepatocellular carcinoma: a tertiary cohort analysis with a nationwide population-based studyJournal of Liver Cancer · 2026
  6. Risk-based hepatocellular carcinoma surveillance thresholds using a prediction score in Asian patients with chronic hepatitis B: a nationwide cohort studyJournal of Liver Cancer · 2026
  7. Stemness plasticity in hepatocellular carcinoma: spatial niches and therapeutic implicationsJournal of Liver Cancer · 2026
  8. Stereotactic body radiation therapy for hepatocellular carcinoma: 2026 expert consensus-based practical recommendation of the Korean Liver Cancer AssociationJournal of Liver Cancer · 2026
  9. Prognostic value of automated CT body composition in hepatocellular carcinoma: a volumetric versus single-slice comparisonJournal of Liver Cancer · 2026
  10. SINEUP-mediated enhancement of HNF4α improves metabolic function in Huh7-based bioengineered hepatic microtissuesJournal of Liver Cancer · 2026
  11. NRF2-Mediated immune evasion and ferroptosis resistance in hepatocellular carcinoma: implications for immune checkpoint inhibitor responseJournal of Liver Cancer · 2026
  12. Enhancing non-LR-5 liver lesion diagnoses: the incremental value of serum alpha-fetoprotein and PIVKA-II for detecting hepatocellular carcinoma componentsJournal of Liver Cancer · 2026
  13. Outcomes of Early-Stage HCC patients treated by resection or ablation: real-life data from the French administrative health care database (SNDS)Journal of Liver Cancer · 2026
  14. Combined hepatocellular-cholangiocarcinoma: a contemporary pathologic and molecular perspectiveJournal of Liver Cancer · 2026
  15. Systemic therapy for combined hepatocellular-cholangiocarcinoma: a comprehensive review of chemotherapy, immunotherapy, and targeted therapyJournal of Liver Cancer · 2026
  16. Contemporary overview of liver transplantation for intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinomaJournal of Liver Cancer · 2026
  17. The role of radiotherapy in the management of combined hepatocellular-cholangiocarcinoma: current evidence and future perspectivesJournal of Liver Cancer · 2026
  18. Imaging differentiation of hepatocellular carcinoma, combined hepatocellular-cholangiocarcinoma, and intrahepatic cholangiocarcinoma: pitfalls and advancesJournal of Liver Cancer · 2026
  19. Liver resection versus radiofrequency ablation or transarterial chemoembolization for early multinodular BCLC-A hepatocellular carcinoma: a systematic review and meta-analysisJournal of Liver Cancer · 2026
  20. Systemic treatment strategies for combined hepatocellular-cholangiocarcinoma: current evidence and future directionJournal of Liver Cancer · 2026
  21. Surgical Management of Intrahepatic Cholangiocarcinoma and Combined Hepatocellular–Cholangiocarcinoma: A Narrative Review of Principles, Technical Nuances, and Emerging StrategiesJournal of Liver Cancer · 2026
  22. Strategic drug sequencing in hepatocellular carcinoma in the era of chemo-diversity: maximizing the therapeutic benefit of lenvatinibJournal of Liver Cancer · 2025
  23. PNPLA3 I148M is unrelated to HCC occurrence but associates with poorer tumor differentiation in Korean MASLD: a prospective cohort of 562 patientsJournal of Liver Cancer · 2025
  24. Systematic review of metabolomic profiles linked to liver cancerJournal of Liver Cancer · 2025
  25. Re-evaluating DAA therapy in active hepatocellular carcinoma: from controversy to clinical considerationsJournal of Liver Cancer · 2025
  26. Surgical treatment of hepatocellular carcinoma: an expert consensus-based practical recommendation from the Korean Liver Cancer AssociationJournal of Liver Cancer · 2025
  27. Impact of the 2024 medical-policy conflict on hepatocellular carcinoma management in KoreaJournal of Liver Cancer · 2025
  28. Preventing False Positive Imaging Diagnosis of HCC: Differentiating HCC from Mimickers and Practical StrategiesJournal of Liver Cancer · 2025
  29. Current status and future perspectives of minimally invasive liver surgery for hepatocellular carcinomaJournal of Liver Cancer · 2025
  30. Association between metabolites and hepatocellular carcinoma: findings from a two-sample Mendelian randomization studyJournal of Liver Cancer · 2025
  31. Navigating Liver Cancer with Mouse Models: A Comprehensive Overview of HCC Experimental SystemsJournal of Liver Cancer · 2025
  32. Public health strategies for hepatocellular carcinoma: from risk factors to prevention and controlJournal of Liver Cancer · 2025
  33. Expert survey on systemic therapy indications for hepatocellular carcinoma in Korea: bridging clinical practice and reimbursement criteriaJournal of Liver Cancer · 2025
  34. Second-line antidiabetic drugs: friend or foe of the liverJournal of Liver Cancer · 2025
  35. Orbital metastasis of hepatocellular carcinoma: rare cause of exophthalmos in chronic liver diseaseJournal of Liver Cancer · 2025
  36. Management of hepatocellular carcinoma in elderly and adolescent/young adult populationsJournal of Liver Cancer · 2025
  37. Identification of new biomarkers of hepatic cancer stem cells through proteomic profilingJournal of Liver Cancer · 2025
  38. Insights into hepatocellular adenomas in Asia: molecular subtypes, clinical characteristics, imaging features, and hepatocellular carcinoma risksJournal of Liver Cancer · 2025
  39. Epidemiology and genomic features of biliary tract cancer and its unique features in KoreaJournal of Liver Cancer · 2025
  40. Hepatocellular carcinoma in Korea: an analysis of the 2016-2018 Korean Nationwide Cancer RegistryJournal of Liver Cancer · 2025
  41. Recent advances and issues in imaging modalities for hepatocellular carcinoma surveillanceJournal of Liver Cancer · 2025
  42. A concise review of updated global guidelines for the management of hepatocellular carcinoma: 2017-2024SHILAP Revista de lepidopterología · 2025
  43. Enhanced radiofrequency ablation for recurrent hepatocellular carcinoma post-transarterial chemoembolization: a prospective study utilizing twin internally cooled-perfusion electrodesJournal of Liver Cancer · 2025
  44. Synergistic effects of L-arginine and argininosuccinate synthetase 1 in inducing apoptosis in hepatocellular carcinomaJournal of Liver Cancer · 2025
  45. Molecular and immune landscape of hepatocellular carcinoma for therapeutic developmentJournal of Liver Cancer · 2024
  46. Multidisciplinary approaches to downstaging hepatocellular carcinoma: Present & FutureJournal of Liver Cancer · 2024
  47. Local ablation for hepatocellular carcinoma: 2024 expert consensus-based practical recommendation of the Korean Liver Cancer AssociationJournal of Liver Cancer · 2024
  48. Evolving trends in treatment patterns for hepatocellular carcinoma in Korea from 2008 to 2022: a nationwide population-based studyJournal of Liver Cancer · 2024
  49. New systemic treatment options for advanced cholangiocarcinomaJournal of Liver Cancer · 2024
  50. Disease modifiers and novel markers in HBV-related HCCJournal of Liver Cancer · 2024